HCV, ribavirin, and anemia: a new dawn

Gastroenterology. 2013 Nov;145(5):930-3. doi: 10.1053/j.gastro.2013.09.036. Epub 2013 Sep 20.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anemia / prevention & control*
  • Erythropoietin / therapeutic use*
  • Female
  • Genotype*
  • Hepacivirus / genetics*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Male
  • Polyethylene Glycols / therapeutic use*
  • Proline / analogs & derivatives*
  • Proline / therapeutic use
  • Recombinant Proteins / therapeutic use
  • Ribavirin / therapeutic use*

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Erythropoietin
  • Polyethylene Glycols
  • Ribavirin
  • N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
  • Proline
  • peginterferon alfa-2b